The plan spent more on Wegovy, a diabetes drug now used for weight loss, than any other medication in 2023. ANP Remko de Waal/ANP/Sipa USA Two high-profile Republican politicians in North Carolina ...

At the hearing, Novo CEO Lars Fruergaard Jørgensen said the company would consider new talks with insurers about the list prices of Wegovy and Ozempic if they follow through on a pledge to keep the ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year ...

The obesity-drug hype that fueled huge gains in Novo Nordisk A/S looks to be running out of steam. Novo shares fell as much as 4.6% to a seven-month low on Friday after a JPMorgan Chase & Co ...

Novo shares fell as much as 4.6% to a seven-month low on Friday after a JPMorgan Chase & Co. analyst said the Danish firm’s third-quarter results may show slower-than-expected sales of its blockbuster ...

The Federal Reserve's preferred inflation gauge is expected to show that price pressures continued to ease gradually in August. The personal-consumption expenditures price index, or PCE ...

Steady newsflow concerning potential rivals to Novo Nordisk’s weight-loss and diabetes drugs Ozempic and Wegovy has dented the investment case, said Soren Lontoft Hansen, senior analyst at ...

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Obesity medicine professionals identified six common mistakes people make on weight ...